Xiu-Li Shi

Indole hybrids as promising anti-hepatocellular carcinoma agents: a comprehensive review of recent advances and therapeutic prospects.

Hepatocellular carcinoma (HCC), the primary type of liver cancer, ranks among the leading causes of cancer-related deaths globally due to its high incidence and poor prognosis. Moreover, the high recurrence rate and acquired resistance to existing therapies further exacerbate the therapeutic challenges of HCC, undersco...